103 related articles for article (PubMed ID: 8784866)
1. Radiochemical purity, at expiry, and radiochemical stability of iodine-131 labelled meta-iodobenzylguanidine concentrates for intravenous infusion.
Wafelman AR; Hoefnagel CA; Maes RA; Beijnen JH
Nuklearmedizin; 1996 Aug; 35(4):122-5. PubMed ID: 8784866
[TBL] [Abstract][Full Text] [Related]
2. Radiochemical purity of iodine-131 labelled metaiodobenzylguanidine infusion fluids: a report from clinical practice.
Wafelman AR; Suchi R; Hoefnagel CA; Beijnen JH
Eur J Nucl Med; 1993 Jul; 20(7):614-6. PubMed ID: 8370383
[TBL] [Abstract][Full Text] [Related]
3. Radiochemical stability during infusion of 131I-labelled metaiodobenzylguanidine for therapeutic use.
Wafelman AR; Hoefnagel CA; Beijnen JH
Nucl Med Commun; 1993 Sep; 14(9):819-22. PubMed ID: 8233249
[TBL] [Abstract][Full Text] [Related]
4. Effects of temperature on radiochemical purity and immunoreactivity of radiolabeled monoclonal antibody 1H10.
Huang WS; Cherng SC; Jen TK; Yu MH; Yeh MY
J Nucl Med Technol; 2000 Sep; 28(3):182-5. PubMed ID: 11001503
[TBL] [Abstract][Full Text] [Related]
5. Renal excretion of iodine-131 labelled meta-iodobenzylguanidine and metabolites after therapeutic doses in patients suffering from different neural crest-derived tumours.
Wafelman AR; Hoefnagel CA; Maessen HJ; Maes RA; Beijnen JH
Eur J Nucl Med; 1997 May; 24(5):544-52. PubMed ID: 9142736
[TBL] [Abstract][Full Text] [Related]
6. 131I-MIBG therapy of neural crest tumours (review).
Troncone L; Rufini V
Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
[TBL] [Abstract][Full Text] [Related]
7. Rapid radiochemical purity testing for [131I]m-iodobenzylguanidine.
Hung JC; Wilson ME
Nucl Med Biol; 1995 Feb; 22(2):227-9. PubMed ID: 7767317
[TBL] [Abstract][Full Text] [Related]
8. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
[TBL] [Abstract][Full Text] [Related]
9. Updating the procedure for metaiodobenzylguanidine labelling with iodine radioisotopes employed in industrial production.
Franceschini R; Mosca R; Bonino C
J Nucl Biol Med (1991); 1991; 35(4):183-5. PubMed ID: 1823814
[TBL] [Abstract][Full Text] [Related]
10. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
Fitzgerald PA; Goldsby RE; Huberty JP; Price DC; Hawkins RA; Veatch JJ; Dela Cruz F; Jahan TM; Linker CA; Damon L; Matthay KK
Ann N Y Acad Sci; 2006 Aug; 1073():465-90. PubMed ID: 17102115
[TBL] [Abstract][Full Text] [Related]
11. Radiochemical purity and in vitro stability of commercial hippurans.
Hammermaier A; Reich E; Bögl W
J Nucl Med; 1986 Jun; 27(6):850-4. PubMed ID: 3712098
[TBL] [Abstract][Full Text] [Related]
12. Does intravenous saline infusion compromise the stability of [123I] meta-iodobenzylguanidine?
Martínez T; Chivato T; Roldán M; Miñana E
Nucl Med Commun; 2014 Jun; 35(6):683-5. PubMed ID: 24637441
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
Weber W; Weber J; Senekowitsch-Schmidtke R
Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
[TBL] [Abstract][Full Text] [Related]
14. Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.
Garaventa A; Pianca C; Conte M; Nigro M; De Bernardi B; Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Villavecchia GP
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):58-60. PubMed ID: 9002751
[TBL] [Abstract][Full Text] [Related]
15. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
Psathas PA; Kuzmission A; Ikeda K; Yasuo S
Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
[TBL] [Abstract][Full Text] [Related]
16. No-carrier-added synthesis of meta-[131I]iodobenzylguanidine.
Vaidyanathan G; Zalutsky MR
Appl Radiat Isot; 1993 Mar; 44(3):621-8. PubMed ID: 8472027
[TBL] [Abstract][Full Text] [Related]
17. Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma.
Howard JP; Maris JM; Kersun LS; Huberty JP; Cheng SC; Hawkins RA; Matthay KK
Pediatr Blood Cancer; 2005 Mar; 44(3):232-9. PubMed ID: 15490487
[TBL] [Abstract][Full Text] [Related]
18. Carrier-free 131I-meta-iodobenzylguanidine: comparison of production from meta-diazobenzylguanidine and from meta-trimethylsilylbenzylguanidine.
Mairs RJ; Gaze MN; Watson DG; Skellern GG; Constable P; McKellar K; Owens J; Vaidyanathan G; Zalutsky MR
Nucl Med Commun; 1994 Apr; 15(4):268-74. PubMed ID: 8072739
[TBL] [Abstract][Full Text] [Related]
19. A gene therapy/targeted radiotherapy strategy for radiation cell kill by.
Boyd M; Mairs RJ; Cunningham SH; Mairs SC; McCluskey A; Livingstone A; Stevenson K; Brown MM; Wilson L; Carlin S; Wheldon TE
J Gene Med; 2001; 3(2):165-72. PubMed ID: 11318115
[TBL] [Abstract][Full Text] [Related]
20. Stabilisation of [131I]meta-iodobenzylguanidine at room temperature as organic extract in ethyl acetate/chloroform.
Chattopadhyay S; Das MK; Sarkar BR; Prabhakar G; Mehra KS; Ramamoorthy N
Appl Radiat Isot; 2001 Feb; 54(2):241-4. PubMed ID: 11200885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
